Back to search

Article

Strengthening Antisense Oligonucleotide-Mediated Anti-Tumor Immunity via Metal-Organic Framework Nanoparticles

2025-04-02

Abstract excerpt

<h4>ABSTRACT</h4> Overexpression of checkpoint proteins, such as programmed death ligand one (PD-L1), prevents immune recognition and enables cancer growth. Current monoclonal antibodies that block PD-L1 tend to be fragile, unable to penetrate tumors, and target cancer at later stages, thus leading to inconsistent patient outcomes. Antisense oligonucleotides (ASOs) provide an alternative to decrease PD-L1 express...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d1de08a3-5b74-5ed0-b60f-845b6c938218
DOI
10.1101/2025.03.28.645811
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Strengthening Antisense Oligonucleotide-Mediated Anti-Tumor Immunity via Metal-Organic Framework NanoparticlesDOI 10.1101/2025.03.28.645811
Select a neighboring publication to make it the new centre.